Hospital Central Dr. Luis Ortega Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2012
NCT02238340
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Hospital Central Dr. Luis Ortega

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 10